Dr. Clay Eugene Stalcup, MD

Dr. Stalcup practices at East Tennessee Addiction Specialists in Maryville, Tennessee.

Dr. Stalcup's NPI, 1750389979, was assigned on July 12, 2005. Dr. Stalcup graduated from University of Tennessee, Hsc, College of Medicine in 2002. Dr. Stalcup holds Tennessee license MD38159.

Dr. Stalcup's primary practice is East Tennessee Addiction Specialists, at 2036 Chilhowee Medical Park, Maryville, TN 37804 in Blount County. The practice phone is (865) 268-4360.

Dr. Stalcup's primary practice is East Tennessee Addiction Specialists in Maryville, Tennessee. Dr. Stalcup is also affiliated with The University of Tennessee Medical Center. The medical group on file is East Tennessee Addiction Specialists. Dmand AI also links Dr. Stalcup to 1 more hospital, 5 medical groups, 4 group practices and clinics and 2 home health agencies, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Stalcup practices, 8 sites in all. Vendor and product names are available with a free account.

Family medicine is Dr. Stalcup's primary specialty in the NPI Registry, under taxonomy code 207Q00000X. Dr. Stalcup is licensed in Tennessee.

CMS data shows 1,273 Medicare services from Dr. Stalcup across 12 procedure codes in 2024, for 240 Medicare patients. Medicare paid $92,160 for them. Every service was in an office.

CMS counts 240 Medicare patients who saw Dr. Stalcup in 2024. The largest group is 65 to 74, with 104 patients. 75% of them have high cholesterol, and 72% have high blood pressure. 9% are also on Medicaid. Their average risk score is 1.13, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Stalcup's median patient age at 51, with 44% women.

In 2024, Dr. Stalcup wrote 11,905 Medicare Part D claims for 617 patients. 89% of them were for generic drugs. CMS names the drug for 11,275 of them, across 148 drugs with 11 or more claims each, at $985,599 in total drug cost. In 2023, CMS named 10,785 claims across 142 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 96 out of 100 for Dr. Stalcup for performance year 2024, reported through an alternative payment model (APM). Dr. Stalcup accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Stalcup as offering telehealth.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 448 general payments to Dr. Stalcup from 41 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Novo Nordisk Inc paid the most, $1,108.

Dr. Stalcup graduated from University of Tennessee, Hsc, College of Medicine in 2002.